Benzinga
10 Apr 2026, 14:57 UTC · 30w ago
Sun Pharma Nears Final Offer For Organon In Largest Overseas Bet
Impact · against what's priced in
The news that Sun Pharma has completed due diligence and is finalizing financing for Organon significantly increases the probability of a deal closing. While OGN shares have already jumped 28%, the shift from a non-binding offer to a firm bid remains a positive catalyst for the target.
- OGN+0.60
No priced-in read yet
- In context
The transition from a non-binding offer to the completion of a three-month due diligence process and the mandating of three global banks significantly increases the likelihood of a final acquisition offer.
Read from the article alone
